Synaffix B.V.

Synaffix B.V. is a biotechnology company that develops ADC product candidates using its clinical-stage, site-specific ADC technology platform.

lots of hats

Biotech

BigHat, Synaffix collab outfits AI science with ADC tech

BigHat is adding Synaffix’s ADC tech to its wardrobe, pairing the science with its antibody design platform to tailor a next-gen ADC pipeline.

Gabrielle Masson Nov 4, 2024 11:07am

Photo of two hands shaking

After halting lead asset, Sotio signs $740M deal with Synaffix

Oct 16, 2023 3:00am

cash

Synaffix, MacroGenics crack open ADC pact, tack on $2.2B to deal

Mar 14, 2023 10:30am

pile of cash piggy bank money cash dollars bills spend

Amgen piles $2B more into pharma's ADC rush

Jan 5, 2023 10:20am

bird birds flying humingbirds

Hummingbird Bio buzzes Synaffix for $150M ADC licensing deal

Jan 4, 2023 11:05am